MoneyWorks4Me

Lupin informs about revised investor presentation

07 Aug 2026 Evaluate
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Investor Presentation (Revised) on the Unaudited Financial Results of the Company for the quarter ended on June 30, 2026

The above information is a part of company’s filings submitted to BSE.  

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..